ERIN BEASLEY: Open Payments
NPI 1679103808 · ALBERTVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$333 in 12 payments from 7 companies in 2025. Trend: 2023 $351 · 2024 $277 · 2025 $333
Food & beverage: $273Consulting: $60
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $99 |
| PFIZER INC. | 3 | $80 |
| Biogen, Inc. | 1 | $60 |
| CSL Behring | 1 | $34 |
| Janssen Biotech, Inc. | 1 | $24 |
| ARGENX US, INC. | 1 | $19 |
| Grifols USA, LLC | 1 | $18 |
Products named: OCTAGAM IMMUNE GLOBULIN (HUMAN), HYQVIA, TYSABRI, Hizentra, CUVITRU, TREMFYA, VYVGART HYTRULO, Gamunex-C.
Industry payments across AL — which companies pay providers there.
